Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis

被引:16
作者
Porrello, A
Soddu, S
Zbilut, JP
Crescenzi, M
Giuliani, A
机构
[1] Regina Elena Inst Canc Res, Dept Expt Oncol, I-00158 Rome, Italy
[2] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA
[3] Ist Super Sanita, Comparat Toxicol & Ecotoxicol Lab, I-00161 Rome, Italy
关键词
database; discriminant analysis; hydrophobicity; mutation; polymorphism; prion; recurrence quantification analysis (RQA);
D O I
10.1002/prot.20075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is mutated in roughly 50% of all human tumors, predominantly in the DNA-binding domain codons. Structural, biochemical, and functional studies have reported that the different p53 mutants possess a broad range of behaviors that include the elimination of the tumor-suppression function of wild-type protein, the acquisition of dominant-negative function over the wild-type form, and the establishment of gain-of-function activities. The contribution of each of these types of mutations to tumor progression, grade of malignancy, and response to anticancer treatments has been so far analyzed only for a few "hot-spots." In an attempt to identify new approaches to systematically characterize the complete spectrum of p53 mutations, we applied recurrence quantification analysis (RQA), a non-linear signal analysis technique, to p53 primary structure. Moving from the study of the p53 hydro-phobicity pattern, which revealed important similarities with the singular deterministic structuring of prions, we could statistically discriminate, on a pure amino acid sequence basis, between experimentally characterized DNA-contact defective and conformational p53 mutants with a very high percentage of success. This result indicates that RQA is a mathematical tool particularly advantageous for the development of a database of p53 mutations that integrates epidemiological data with structural and functional categorizations. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:743 / 755
页数:13
相关论文
共 100 条
[1]  
Abkevich VI, 1998, PROTEINS, V31, P335, DOI 10.1002/(SICI)1097-0134(19980601)31:4<335::AID-PROT1>3.3.CO
[2]  
2-C
[3]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[4]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[5]  
BARTEK J, 1990, ONCOGENE, V5, P893
[6]   Pathway complexity of prion protein assembly into amyloid [J].
Baskakov, IV ;
Legname, G ;
Baldwin, MA ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21140-21148
[7]   IS P53 POLYMORPHISM MAINTAINED BY NATURAL-SELECTION [J].
BECKMAN, G ;
BIRGANDER, R ;
SJALANDER, A ;
SAHA, N ;
HOLMBERG, PA ;
KIVELA, A ;
BECKMAN, L .
HUMAN HEREDITY, 1994, 44 (05) :266-270
[8]   p53 contains large unstructured regions in its native state [J].
Bell, S ;
Klein, C ;
Müller, L ;
Hansen, S ;
Buchner, J .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 322 (05) :917-927
[9]   p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis [J].
Bergamaschi, D ;
Gasco, M ;
Hiller, L ;
Sullivan, A ;
Syed, N ;
Trigiante, G ;
Yulug, I ;
Merlano, M ;
Numico, G ;
Comino, A ;
Attard, M ;
Reelfs, O ;
Gusterson, B ;
Bell, AK ;
Heath, V ;
Tavassoli, M ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
CANCER CELL, 2003, 3 (04) :387-402
[10]   Prion protein gene polymorphisms in natural goat scrapie [J].
Billinis, C ;
Panagiotidis, CH ;
Psychas, V ;
Argyroudis, S ;
Nicolaou, A ;
Leontides, S ;
Papadopoulos, O ;
Sklaviadis, T .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :713-721